A recent report published by
Infinium Global Research on atrial fibrillation surgery market provides
in-depth analysis of segments and sub-segments in the global as well as
regional atrial fibrillation surgery market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
atrial fibrillation surgery market over the short term as well as long term.
The report is a comprehensive presentation of trends, forecast, and dollar
values of global atrial fibrillation surgery market. According to the report,
the global atrial fibrillation surgery market is projected to grow at a CAGR of
13.7% over the forecast period of 2020-2026.
Surgical treatment is greatly
effective in converting atrial fibrillation back to sinus rhythm and
considerably prevents thromboembolism postoperatively. According to WHO, atrial
fibrillation is the most common type of arrhythmia and 8% of people over the
age of 80 suffer from some form of atrial fibrillation. The incidence of atrial
fibrillation continues to increase worldwide as people live longer and industry
responded to this problem with advanced technologies and a plethora of
The factors such as the surging
volume of patients suffering from heart-related disorders and increasing
preferences towards catheter ablation for cardiac arrhythmia treatment enhance
the growth of the atrial fibrillation market. During the coronavirus pandemic,
atrial fibrillation turned out to be a common clinical manifestation in
hospitalized patients with covid-19. Over the medium and short term, the market
for atrial fibrillation surgery is expected to propel due to rising cases of
atrial fibrillation in the aging population. Moreover, monitoring devices such
as single lead ECG adhesives sensors, implantable loop recorders, smartphone
attachments, and wearables are influencing the growth trajectory of the atrial
fibrillation surgery market. However, a shortage of skilled and trained
professionals is expected to hamper the atrial fibrillation market growth. The
increasing advancement in technology along with growing applications from
emerging countries will further bring various opportunities for the growth of
the global atrial fibrillation market. Coronavirus disease outbreak is a public
health emergency of international concerns because of a highly pathogenic human
coronavirus. Coronavirus affects the respiratory system, primarily the lungs.
But it could also affect the heart, especially a diseased heart that has
previously been struggling to get oxygenated blood all over the body. Due to
which the demand for atrial fibrillation has increased in pandemic duration.
Among the regions, North America
is expected to hold the largest share in the global atrial fibrillation surgery
market with the steady growth of stand-alone SA operations. Patient selection,
improvement of surgical techniques, and long-term follow-ups are the factors
impacting the market growth in this region.
Moreover, a favorable regulatory scenario is impacting the growth of the
market in this region. The U.S. is the foremost revenue contributor in the
North America region. According to American Heart Association (AHA), each year
about 200,000 to 400,000 new atrial fibrillation cases found in the U.S.
Further, the Asia Pacific region is expected to witness steady growth due to
the prevalence of atrial fibrillation in this region. Also, adaptive and
business-friendly regulatory policies in Asia Pacific countries are contributing
to the growth of the market in this region.
The report on global atrial
fibrillation surgery market covers segments such as product, procedures, and
end-user. On the basis of product, the sub-markets include catheter ablation
product, and surgical ablation product. On the basis of procedures, the
sub-markets include catheter ablation procedure, and surgical ablation
procedure. On the basis of end-user, the sub-markets include hospitals,
clinics, and others.
The report provides profiles of
the companies in the market such as Biosense Webster, Inc., Medtronic, Inc.,
St. Jude Medical, Inc., Boston Scientific Corporation, Atricure, Inc.,
Cardiofocus, Inc., Ncontact, Inc., Carima, Inc., Biotroik Se & Co.kg, and
Johnsons & Johnson Ltd.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of atrial fibrillation surgery market. Moreover, the study highlights
current market trends and provides forecast from 2020-2026. We also have
highlighted future trends in the market that will affect the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.